Form 4: Humana Director Kurt J. Hilzinger Reports Changes in Beneficial Ownership

Director Kurt J. Hilzinger reports acquisition of Humana stock units through director fees and dividend reinvestments, deferred until resignation.

Summary

• On March 28, 2024, Kurt J. Hilzinger, a director of Humana Inc., reported changes in his beneficial ownership of the company's securities.
• He acquired 270 restricted stock units (RSUs) at a price of $348.4148 per unit.
• These RSUs were obtained through the conversion of director's cash fees into stock units.
• Hilzinger also holds 22,821 RSUs representing annual director's fees payable in stock units, deferred until his resignation.
• Additionally, he holds 2,188 RSUs from reinvested director's dividend payments on vested and deferred stock units, also deferred until resignation.
• He directly owns 19,448 shares of Humana common stock.
• 430 restricted stock units vest on 12/31/2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a director's stock transactions, neither particularly positive nor negative.

Positives

• The director's continued investment in the company, through the acquisition of stock units, could be seen as a positive signal.

Future Outlook

The reporting person's deferred stock units will be payable in Humana Inc. common stock on a 1-for-1 basis upon resignation of services as a director.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates a director's ongoing investment in the company.

Comparison to Industry Standards

• Director compensation in the form of stock and stock units is a common practice among publicly traded companies, including Humana's competitors like UnitedHealth Group (UNH) and CVS Health (CVS).
• Deferred compensation plans, where stock units are paid out upon resignation or retirement, are also frequently used to align director interests with long-term shareholder value.
• The specific amount and vesting schedules of these awards can vary significantly based on company size, performance, and individual director agreements.

Stakeholder Impact

• The director's continued investment in the company may be viewed positively by shareholders.

Key Dates